| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b7c2c9cf70365ecb3c9bac134718541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_286c39e00007d49b9008db0df46542aa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
| filingDate |
2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6707150478f898330d7651cee1d6ef57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e901a2d317571ec23a88b5504829d48a |
| publicationDate |
2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006115289-A1 |
| titleOfInvention |
Combination of a cyanopyrrolidine with a hepatic gluconeogenesis inhibitor |
| abstract |
A medicament comprising a cyanopyrrolidine derivative having a supeirior DPP-IV inhibitory activity in combination with a hepatic gluconeogenesis inhibitor, which medicament provides a prophylactic or therapeutic agent for diabetes having an effective hypoglycemic action with few side effects in many diabetic patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008113000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007035665-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143217-B2 |
| priorityDate |
2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |